GOLKYPA
Live / Allowed — Second extension granted (statement of use) (as of 26 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 26 Aug 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98716504
- Mark type
- Word mark
- Filed
- 26 Aug 2024
- Published for opposition
- 15 Jul 2025
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biological preparations for human use in the fields of hematology, oncology and cell therapy for the treatment of cancer and blood disorders.
Owner
- Celgene Corporation, Princeton, NJ, US
- Celgene Corporation, Princeton, NJ, US
Prosecution history
- 26 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Aug 2026 — SOU EXTENSION 2 GRANTED
- 26 Aug 2026 — SOU EXTENSION 2 FILED
- 26 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 12 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Feb 2026 — SOU EXTENSION 1 GRANTED
- 12 Feb 2026 — SOU EXTENSION 1 FILED
- 12 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 09 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Jul 2025 — PUBLISHED FOR OPPOSITION
- 09 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE